CVR number 41203544
Industry 75.0000 Veterinary activities

Nybrovej Dyreklinik ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 7.4% 5.4% 6.0% 6.2%  
Credit score (0-100)  0 33 40 38 37  
Credit rating  N/A BB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 6,210 4,772 5,011 5,859  
EBITDA  0.0 2,202 946 1,211 2,326  
EBIT  0.0 1,525 381 921 2,036  
Pre-tax profit (PTP)  0.0 1,385.2 345.6 889.4 2,025.6  
Net earnings  0.0 1,079.5 267.8 685.4 1,578.3  
Pre-tax profit without non-rec. items  0.0 1,385 346 889 2,026  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 545 555 480 370  
Shareholders equity total  0.0 1,122 339 825 1,703  
Interest-bearing liabilities  0.0 455 1,467 1,367 1,270  
Balance sheet total (assets)  0.0 2,960 2,471 2,530 3,617  
Net Debt  0.0 10.8 1,123 586 -963  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 6,210 4,772 5,011 5,859  
Gross profit growth  0.0% 0.0% -23.2% 5.0% 16.9%  
Employees  0 6 6 8 7  
Employee growth %  0.0% 0.0% 0.0% 33.3% -12.5%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 2,960 2,471 2,530 3,617  
Balance sheet change%  0.0% 0.0% -16.5% 2.4% 43.0%  
Added value  0.0 2,202.0 945.6 1,485.6 2,326.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 1,405 -1,102 -546 -581  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 24.6% 8.0% 18.4% 34.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 51.5% 14.0% 36.8% 66.4%  
ROI %  0.0% 96.7% 22.5% 46.1% 79.0%  
ROE %  0.0% 96.3% 36.7% 117.8% 124.9%  

Solidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 37.9% 13.7% 32.6% 47.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.5% 118.8% 48.4% -41.4%  
Gearing %  0.0% 40.6% 432.4% 165.7% 74.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 61.4% 3.7% 2.2% 1.1%  

Liquidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.3 0.3 0.6 1.5  
Current Ratio  0.0 0.5 0.4 0.7 1.7  
Cash and cash equivalent  0.0 444.6 343.7 780.5 2,232.4  

Capital use efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -994.7 -1,153.7 -416.3 1,048.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 367 158 186 332  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 367 158 151 332  
EBIT / employee  0 254 63 115 291  
Net earnings / employee  0 180 45 86 225